Position in ABBV
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$219,430
+$9,192 QoQ
Shares Held
872
-4.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
17 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026EARNEST PARTNERS LLC holds $139,876,807 across 4 Drug Manufacturers - General names. ABBV ranks #4 (0.2% of the industry book) .
All Filings in ABBV
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $219,430 | 872 | Shares | Sole | 2026-08-13 | |
| 2025-09-30 | $210,238 | 908 | Shares | Sole | 2025-11-14 | |
| 2023-09-30 | $126,253 | 847 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $114,116 | 847 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $134,986 | 847 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $136,883 | 847 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $113,675 | 847 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $129,726 | 847 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $137,307 | 847 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $114,683 | 847 | Shares | Sole | 2022-02-07 | |
| 2021-09-30 | $91,365 | 847 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $95,406 | 847 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $91,662 | 847 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $90,756 | 847 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $74,188 | 847 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $83,158 | 847 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $53,942 | 708 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||